Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: FRExchange: Nasdaq
DilutionScan read 32 of Innate Pharma SA's SEC filings and found 5 warrant series, 4 convertibles, 1 ATM program, 1 shelf registration and 1 completed offering on file for IPHA. The latest dilution event on file is an offering on Aug 18, 2026. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
STROSutro Biopharma, Inc.
CNTNCanton Strategic Holdings Inc
PDSBPDS Biotechnology Corporation
ALXOALX Oncology Holdings Inc.
YARWYarrow Bioscience Inc
ADAGAdagene Inc. American Depositary Shares
ANTXAN2 Therapeutics, Inc.
MGNXMacroGenics, Inc.
VRXAVeraxa Biotech AG Ordinary Shares
PEPGPepGen Inc.
MXCTMaxCyte, Inc.
CUECue Biopharma, Inc.
TARAProtara Therapeutics, Inc.
ORMPOramed Pharmaceuticals Inc.
NGENNervGen Pharma Corp. Common stock